ELFN2 Gene - Extracellular Leucine Rich Repeat And Fibronectin Type III Domain Containing 2

Comprehensive genomic and proteomic analysis of ELFN2, a gene encoding a synaptic adhesion protein implicated in neurological disorders and cancer.

Gene Information Card

Symbol ELFN2
Full Name Extracellular Leucine Rich Repeat And Fibronectin Type III Domain Containing 2
Gene Type Protein coding
Chromosomal Location 22q13.1
NCBI Gene ID 114794 ncbi.nlm.nih.gov/gene/114794
Ensembl ID ENSG00000100234
UniProt ID Q5T0F9
OMIM ID 616489
HGNC ID 28008
Aliases FLJ32709, MGC131914, PPP1R29

Description

ELFN2 encodes a protein containing leucine-rich repeats (LRRs) and fibronectin type III domains, characteristic of synaptic adhesion molecules. It is involved in the regulation of synaptic transmission and has been associated with neurodevelopmental disorders. The gene is also implicated in certain cancers through somatic mutations and altered expression.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Neurodevelopmental disorder with language delay and intellectual disability Disruption of synaptic adhesion and signaling OMIM #616489; rare missense variants reported in affected individuals
Autism spectrum disorder Altered synaptic function due to ELFN2 variants ClinVar; case-control studies
Colorectal cancer Somatic mutations and differential expression COSMIC; TCGA data

Expression Profile

Tissue Expression
Tissue nTPM level
Brain 12.5 Medium
Testis 8.3 Low
Lung 4.1 Low
Liver 1.2 Not detected
Kidney 2.8 Low
Cell Line Expression
Cell Line nTPM Notes
SH-SY5Y (neuroblastoma) 15.0 Neuronal model; high expression
HEK293 (embryonic kidney) 3.5 Low endogenous expression
HCT116 (colorectal carcinoma) 6.2 Moderate expression
A549 (lung carcinoma) 2.1 Low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1015C>T (p.Arg339Trp) Missense <0.01% Altered protein stability; reported in neurodevelopmental disorder
c.1246G>A (p.Gly416Arg) Missense <0.01% Impaired synaptic localization; ClinVar
c.1789_1790insA (p.Thr597Asnfs*12) Frameshift <0.001% Loss of function; COSMIC colorectal cancer
Mutation functional classification

Loss of Function (LOF)

Frameshift and nonsense mutations leading to truncated protein; observed in cancer and neurodevelopmental cases.

Gain of Function (GOF)

Not well characterized; some missense variants may alter protein interactions.

Dominant Negative (DN)

Not reported for ELFN2.

Gene Ontology (GO)

• GO:0005886 - plasma membrane • GO:0007156 - homophilic cell adhesion via plasma membrane adhesion molecules
• GO:0007268 - chemical synaptic transmission • GO:0030424 - axon
• GO:0045202 - synapse

Pathways

Synaptic adhesion and signaling (Reactome R-HSA-6794362)
Neuronal system (Reactome R-HSA-112316)

Protein Summary

The ELFN2 protein is a single-pass type I membrane protein with extracellular LRR and fibronectin type III domains. It localizes to synapses and mediates cell adhesion and synaptic signaling. The protein is expressed predominantly in the brain and testis, with lower levels in other tissues. Structural integrity is critical for its role in neuronal connectivity.

Related Products

Product name Cat.No. Species Gene ID
ELFN2 Knockout HEK293 Cell Line EDJ-KQ7467 Human 114794 Details Get a Quote
ELFN2 Knockout A-549 Cell Line EDJ-KQ32684 Human 114794 Details Get a Quote
ELFN2 Knockout HCT 116 Cell Line EDJ-KQ32685 Human 114794 Details Get a Quote
ELFN2 Knockout HeLa Cell Line EDJ-KQ32686 Human 114794 Details Get a Quote
ELFN2 Knockout HAP1 Cell Line EDC08285 Human 114794 Details Get a Quote
Displaying Records 1 To 5 Of 5 Records
Contact Us
*
*
*
*
How did you hear about us: